The 22nd Annual Congress of ERS in Vienna, Austria
In September 2012 I participated in the 22nd Annual Congress of the European Respiratory Society. This year it was held in Vienna, Austria on 1-5 September with over 12,000 doctors and specialists in respiratory medicine attended.
Dozens of symposia, presentations, and discussions were held daily. The most topical issues of diagnosis, treatment, prevention, and rehabilitation of pulmonary medicine were presented and discussed. One of those issues is PR COPD, and many studies were devoted to it. Definition of PR COPD was adopted in 2006 by ATS/ERS Group.
We got to know more about COPD in the last years: about its complex nature, about systemic manifestations of the disease, and about psycho-emotional status of patients. Representation of the goals and purposes of PR COPD is therefore changing — more and more attention is now given to the custom (i.e. personalized) approach. One of hot topics of Congress was presentation and discussion on the new definition of PR COPD, which will be adopted by ATS/ERS in the near future. Much attention was given to various methods and techniques of PR COPD — there is a constant search for new and effective methods help pulmonary patients.
The results of our research “Dry sodium chloride aerosol in rehabilitation of patients with COPD”, implemented jointly with Polish colleagues were presented at session “The latest insights in pulmonary rehabilitation”. In rehabilitation clinic of a resort in Poland we have conducted a randomized placebo-study and got a positive effect of dry salt of sodium chloride in the method of controlled halotherapy in patients with mild to moderate COPD. (Full-size E-poster 0.9 MB )
Halotherapy explained by its creator
Definition of the Controlled Halotherapy, dry salt aerosol, mechanisms of action, efficiency, and realization.
Featured publications on Halotherapy
Articles and publications on Halotherapy by prof. Alina V. Chervinskaya available for download in PDF-format.
Informational product HaloCARE™
Practical experience of the Controlled Halotherapy application based on the results of clinical studies.